BETA


2016/0261(COD) New psychoactive substances: information exchange, early warning system and risk assessment procedure

Progress: Procedure completed

RoleCommitteeRapporteurShadows
Lead LIBE BONI Michał (icon: PPE PPE)
Committee Opinion ENVI BUŞOI Cristian-Silviu (icon: PPE PPE) Elena GENTILE (icon: S&D S&D), Jasenko SELIMOVIC (icon: ALDE ALDE)
Lead committee dossier:
Legal Basis:
TFEU 168-p5

Events

2017/12/06
   EC - Commission response to text adopted in plenary
Documents
2017/11/21
   Final act published in Official Journal
Details

PURPOSE: to strengthen the EU's early warning system and risk assessment procedure for new psychoactive substances (NPS).

LEGISLATIVE ACT: Regulation (EU) 2017/2101 of the European Parliament and of the Council amending Regulation (EC) No 1920/2006 as regards information exchange on, and an early warning system and risk assessment procedure for, new psychoactive substances.

CONTENT: this Regulation amends Regulation (EC) No 1920/2006 in order to strengthen surveillance and improve the early warning system and to assess the health and social risks associated with new psychoactive substances. The Regulation shall take into account that vulnerable groups , especially young people, are particularly exposed to the risks associated with these new substances.

The main amendments adopted concern the following points:

Exchange of information, early warning system and risk assessment : each Member State shall ensure that its national focal point and Europol national units provide the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the necessary information they have on the NSPs.

The Centre, in cooperation with Europol, shall collect, collate, analyse and assess the information and communicate it in a timely manner to the national focal points and the Europol national units as well as to the Commission with a view to providing them with any information required for the purposes of early warning and for the purposes of allowing the Centre to draw up the initial report.

Initial report : where the Centre, the Commission or a majority of the Member States considers that information shared on a new psychoactive substance collected in one or more Member States gives rise to concerns that the new psychoactive substance may pose health or social risks at Union level, the Centre shall draw up an initial report on the new psychoactive substance.

The initial report shall allow the Commission to make an informed decision regarding the launch of the risk assessment procedure. Europol, the European Medicines Agency, the European Centre for Disease Prevention and Control, the European Chemicals Agency and the European Food Safety Authority shall be involved in collecting information for the preparation of the initial reports.

Risk assessment procedure and report : within two weeks of receipt of an initial report, the Commission may request the Centre to assess the potential risks posed by the new psychoactive substance and to draw up a risk assessment report. The Centre shall submit the risk assessment report or the combined risk assessment report to the Commission and the Member States within six weeks of receipt of the request from the Commission to draw up a risk assessment report. Following the risk assessment procedure, the Commission shall determine whether the new psychoactive substance in question should be included in the definition of ‘drug’ in accordance with the procedure provided for in Council Framework Decision 2004/757/JHA .

Exclusion from risk assessment : no risk assessment shall be carried out where the new psychoactive substance is at an advanced stage of assessment within the United Nations system.

No risk assessment shall be carried out where the new psychoactive substance is an active substance in a medicinal product for human use or in a veterinary medicinal product that has obtained a marketing authorisation.

ENTRY INTO FORCE: 22.11.2017.

APPLICATION: from 23.11.2018.

2017/11/15
   CSL - Draft final act
Documents
2017/11/15
   CSL - Final act signed
2017/11/15
   EP - End of procedure in Parliament
2017/11/10
   EP/CSL - Act adopted by Council after Parliament's 1st reading
2017/11/10
   CSL - Council Meeting
2017/10/24
   EP - Results of vote in Parliament
2017/10/24
   EP - Decision by Parliament, 1st reading
Details

The European Parliament adopted by 609 votes to 19, with 29 abstentions, a resolution on the proposal for a regulation of the European Parliament and of the Council amending Regulation (EC) No 1920/2006 as regards information exchange, early warning system and risk assessment procedure on new psychoactive substances.

The European Parliament’s position adopted at first reading under the ordinary legislative procedure amended the Commission proposal as follows:

Improving monitoring : given the rapidly growing market for these new products, which remains challenging, the amended text stressed the need to enhance monitoring and early warning systems and to assess their health and social risks.

Vulnerable groups , especially young people, are particularly exposed to the health and social risks associated with new psychoactive substances.

Exchange of information, early warning system and risk assessment : the European Monitoring Center for Drugs and Drug Addiction (EMCDDA) in cooperation with Europol shall collect, collate, analyse and assess the information and communicate it in a timely manner to the national focal points and the Europol national units as well as to the Commission with a view to providing them with any information required for the purposes of early warning and for the purposes of allowing the Centre to draw up the initial report or the combined initial report.

Initial report : an initial report shall be drawn up on a new psychoactive substance where information provided by the Member States on that new psychoactive substance gives rise to concerns that it might pose health or social risks at Union level. The initial report shall allow the Commission to make an informed decision regarding the launch of the risk assessment procedure. The risk assessment procedure at Union level should be undertaken rapidly.

Where the a majority of the Member States considers that information shared on a new psychoactive substance gives rise to concerns that the new psychoactive substance may pose health or social risks at Union level, the Centre shall draw up an initial report on the new psychoactive substance.

The amended text stated that the initial report shall contain a first indication of the nature, number and scale of incidents showing health and social problems in which the new psychoactive substance may potentially be involved, and the patterns of use of the new psychoactive substance.

The initial report shall also contain information:

on the human and veterinary medical use of the new psychoactive substance, including as an active substance in a medicinal product for human use or in a veterinary medicinal product; on the commercial and industrial use of the new psychoactive substance, the extent of such use, as well as its use for scientific research and development purposes.

The Scientific Committee may be extended as deemed necessary by including experts representing the scientific fields relevant for ensuring a balanced assessment of the risks posed by the new psychoactive substance.

Following the risk assessment procedure, the Commission shall determine whether the new psychoactive substance in question should be included in the definition of 'drug' in accordance with the procedure provided for in Council Framework Decision 2004/757/JHA.

Exclusion from risk assessment : in principle, no risk assessment shall be carried out on a new psychoactive substance if it is subject to an assessment under international law , except where there are sufficient data and information available to suggest the need for a risk assessment report at Union level, the reasons for which shall be indicated in the initial report. In addition, no risk assessment shall be carried out on a new psychoactive substance if it is an active substance in a medicinal product for human use or in a veterinary medicinal product.

Documents
2017/10/23
   EP - Debate in Parliament
2016/11/30
   EP - Committee report tabled for plenary, 1st reading
Details

The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Michal BONI (EPP, PL) on the proposal for a regulation of the European Parliament and of the Council amending Regulation (EC) No 1920/2006 as regards information exchange, early warning system and risk assessment procedure on new psychoactive substances.

The committee recommended that Parliament’s position adopted in first reading following the ordinary legislative procedure should amend the Commission proposal as follows:

Improve monitoring : bearing in mind the rapid growth of the market of those novel products, which continues to be challenging, the amended text stressed the need to enhance monitoring and early warning systems , to assess their health, safety and social risks in order to develop responses such as risk reduction measures in order to combat those threats.

The Regulation should take into account the fact that vulnerable groups , and especially young people, are particularly exposed to the public health, safety and social risks arising from new psychoactive substances.

Exchange of information, early warning system and risk assessment : Members proposed that provisions on new trends in the use of existing psychoactive substances should be maintained. Information provided to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and to Europol should also include distribution channels, trafficking and smuggling . The Centre, in cooperation with Europol, shall collect, analyse, assess, and communicate this information in a timely manner to Member States and to the Commission.

The initial report on the new psychoactive substance should also give a first indication of safety risks . As one of the reasons of this report is to make the procedures limiting the dangerous new psychoactive substances shorter and more efficient, the information should be provided without undue delay to the Centre by the European Medicines Agency.

Risk assessment report : this must contain:

an analysis of the health risks associated with the new psychoactive substance, including contraindications for use with other substances, where available; an analysis of the social risks associated with the new psychoactive substance, in particular the involvement of criminal groups in the development, manufacture, distribution and distribution channels, trafficking and smuggling of the new psychoactive substance.

The Scientific Committee assessing the risks posed by the new psychoactive substance may include a psychologist specialising in addiction.

Exclusion from risk assessment : a substance not assumed dangerous on the international level could pose serious threats in the EU. Accordingly, if the data indicates this is needed, Members consider that it should be possible to conduct a risk assessment at Union level.

Documents
2016/11/17
   EP - Vote in committee, 1st reading
2016/11/17
   EP - Committee decision to open interinstitutional negotiations with report adopted in committee
2016/11/11
   PT_PARLIAMENT - Contribution
Documents
2016/11/09
   EP - Committee opinion
Documents
2016/10/28
   EP - Amendments tabled in committee
Documents
2016/10/20
   IT_SENATE - Contribution
Documents
2016/10/10
   EP - BUŞOI Cristian-Silviu (PPE) appointed as rapporteur in ENVI
2016/10/03
   EP - BONI Michał (PPE) appointed as rapporteur in LIBE
2016/09/30
   EP - Committee draft report
Documents
2016/09/12
   EP - Committee referral announced in Parliament, 1st reading
2016/08/29
   EC - Legislative proposal published
Details

PURPOSE: to amend Regulation (EC) No 1920/2006 as regards information exchange, early warning system and risk assessment procedure on new psychoactive substances (NPS).

PROPOSED ACT: Regulation of the European Parliament and of the Council.

ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council.

BACKGROUND: new psychoactive substances can pose serious cross border threats to health which makes necessary to enhance monitoring, early warning and combating of those threats.

In 2015, 100 new substances were reported for the first time to the EU Early Warning System (EWS), bringing the total number of new substances monitored to more than 560 – with more than 380 (70%) of these detected in the last five years alone.

On 17 September 2013, the Commission put forward a package of two legislative proposals on new psychoactive substances: (i) a proposal for a Regulation on new psychoactive substances and; (ii) a proposed Directive amending Council Framework Decision 2004/757/JHA laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking, as regards the definition of drug.

Inter-institutional negotiations of this legislative package have been ongoing for more than two years . The European Parliament adopted its legislative resolutions on 17 April 2014. The Council did not adopt a general approach on the proposals; during the examination of the proposals Member States expressed doubts concerning the choice of Article 114 of the Treaty on the Functioning of the European Union (TFEU) as the legal basis for the proposed Regulation.

In response to the agreement by COREPER on 6 April 2016 on a compromise approach proposed by the Netherlands Presidency of the Council to achieve the same objective of a swifter, more effective EU action on NPS, the Commission proposes targeted amendments of Regulation 1920/2006 integrating the draft provisions on early warning system and risk assessment procedure that were part of the 2013 Commission proposal for a Regulation on new psychoactive substances into the founding Regulation of the EMCDDA.

The proposal reflects the priorities set out by the European Agenda on Security adopted on 28 April 2015.

CONTENT: this proposal - based on Article 168(5) TFEU - seeks to amend Regulation (EC) No 1920/2006 in order to strengthen the EU early warning system and the risk assessment and streamline procedures to ensure more effective and fast action.

In order to speed up the process, deadlines are substantially shortened compared to the current system based on Council Decision 2005/387/JHA.

For the purpose of swift and effective collection of information on NPS, the EMCDDA should conclude working arrangements with Europol, the European Medicines Agency, the European Chemicals Agency and the European Food Safety Authority without undue delay following the publication of the Regulation in the Official Journal.

This proposal also ensures a participation of EUROPOL in the early warning system and risk assessment procedure, in particular as input on the involvement of criminal groups in the manufacture and distribution of new psychoactive substances is concerned.

According to Article 23 of Regulation 1920/2006 the Commission may propose, if appropriate, and in the light of developments in respect of regulatory agencies on the basis of the next evaluation of the Centre further amendments to the EMCDDA founding Regulation

The following amendments to Regulation 1920/2006 seek to:

clarify that tasks of the EMCDDA are information exchange and early warning on new psychoactive substances as well as risk assessment. The Centre also monitors all new psychoactive substances that have been reported by Member States; establish the respective roles of Member States, the EMCDDA and Europol in the process of exchange of information and early warning on new psychoactive substances; lay down the contents and the procedures for the drawing up and the transmission by the EMCDDA of an initial report on a new psychoactive substance. Europol, the European Medicines Agency, the European Chemicals Agency and the European Food Safety Authority are associated to the collection of information for an initial report; empower the Commission to request the EMCDDA to assess the risks of a new psychoactive substance on which an initial report has been drawn up. The proposal lays down the procedures for the risk assessment, which is to be conducted by the Scientific Committee of the EMCDDA, and for the drawing up and the transmission of a risk assessment report; detail circumstances in which no risk assessment is to be conducted on a new psychoactive substance.

BUDGETARY IMPLICATIONS: the subsidy for the Centre forms already part of the Union's budget. However, for the Centre to adequately deal with the growing number of requests related to information exchange on new psychoactive substances as well as with the proposed streamlined procedures for the EU early warning system and risk assessment procedure, an amount of EUR 676 000 in total for the period 2017-2020 for the system development and an amount of EUR 100 000 per year to finance three additional contract agents will need to be added to the Centre's budget.

Documents

Activities

Votes

A8-0359/2016 - Michał Boni - Am 23 24/10/2017 12:46:41.000 #

2017/10/24 Outcome: +: 609, 0: 29, -: 19
DE IT FR PL ES GB RO BE PT SE AT HU CZ BG NL EL FI HR DK SK LT IE LV LU SI MT EE CY
Total
84
61
61
48
43
62
30
21
20
18
18
18
18
15
24
18
11
11
11
11
8
9
7
6
6
6
5
5
icon: PPE PPE
189

Sweden PPE

2

Finland PPE

For (1)

1

Denmark PPE

For (1)

1

Lithuania PPE

1

Luxembourg PPE

3

Slovenia PPE

3

Estonia PPE

For (1)

1

Cyprus PPE

1
icon: S&D S&D
175

Czechia S&D

3

Netherlands S&D

3

Greece S&D

2

Croatia S&D

2

Ireland S&D

For (1)

1

Latvia S&D

1

Luxembourg S&D

For (1)

1

Slovenia S&D

For (1)

1

Malta S&D

3

Estonia S&D

For (1)

1

Cyprus S&D

2
icon: ECR ECR
65

Italy ECR

2

Romania ECR

For (1)

1

Bulgaria ECR

2

Netherlands ECR

2

Greece ECR

For (1)

1
2

Croatia ECR

For (1)

1

Lithuania ECR

1

Latvia ECR

For (1)

1
icon: ALDE ALDE
58

Germany ALDE

2

United Kingdom ALDE

1

Romania ALDE

3

Portugal ALDE

1

Austria ALDE

For (1)

1

Croatia ALDE

2

Denmark ALDE

2
2

Ireland ALDE

For (1)

1

Latvia ALDE

1

Luxembourg ALDE

For (1)

1

Slovenia ALDE

For (1)

1

Estonia ALDE

2
icon: Verts/ALE Verts/ALE
50

Italy Verts/ALE

For (1)

1

Belgium Verts/ALE

2

Austria Verts/ALE

3

Hungary Verts/ALE

2

Netherlands Verts/ALE

2

Finland Verts/ALE

For (1)

1

Croatia Verts/ALE

For (1)

1

Denmark Verts/ALE

For (1)

1

Lithuania Verts/ALE

For (1)

1

Latvia Verts/ALE

1

Luxembourg Verts/ALE

For (1)

1

Slovenia Verts/ALE

For (1)

1

Estonia Verts/ALE

For (1)

1
icon: GUE/NGL GUE/NGL
41

Italy GUE/NGL

Abstain (1)

2

Portugal GUE/NGL

3

Sweden GUE/NGL

For (1)

1

Netherlands GUE/NGL

For (1)

3

Finland GUE/NGL

For (1)

1

Denmark GUE/NGL

For (1)

1

Ireland GUE/NGL

Abstain (1)

3

Cyprus GUE/NGL

2
icon: NI NI
15

Germany NI

2

France NI

Abstain (1)

2

Poland NI

Abstain (1)

2

United Kingdom NI

3

Hungary NI

For (1)

1
icon: ENF ENF
27

Poland ENF

Abstain (1)

1

Romania ENF

1

Belgium ENF

For (1)

1

Netherlands ENF

4
icon: EFDD EFDD
35

France EFDD

3

Poland EFDD

1

Sweden EFDD

2

Czechia EFDD

Against (1)

1

Lithuania EFDD

For (1)

1
AmendmentsDossier
46 2016/0261(COD)
2016/10/19 ENVI 23 amendments...
source: 592.263
2016/10/28 LIBE 23 amendments...
source: 593.828

History

(these mark the time of scraping, not the official date of the change)

docs/0/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE589.454
New
https://www.europarl.europa.eu/doceo/document/LIBE-PR-589454_EN.html
docs/1/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE593.828
New
https://www.europarl.europa.eu/doceo/document/LIBE-AM-593828_EN.html
docs/2/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE592.081&secondRef=02
New
https://www.europarl.europa.eu/doceo/document/ENVI-AD-592081_EN.html
docs/4/docs/0/url
/oeil/spdoc.do?i=27940&j=0&l=en
events/1/type
Old
Committee referral announced in Parliament, 1st reading/single reading
New
Committee referral announced in Parliament, 1st reading
events/2/type
Old
Vote in committee, 1st reading/single reading
New
Vote in committee, 1st reading
events/4
date
2016-11-30T00:00:00
type
Committee report tabled for plenary, 1st reading
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/A-8-2016-0359_EN.html title: A8-0359/2016
summary
events/4
date
2016-11-30T00:00:00
type
Committee report tabled for plenary, 1st reading/single reading
body
EP
docs
url: http://www.europarl.europa.eu/doceo/document/A-8-2016-0359_EN.html title: A8-0359/2016
summary
events/5/docs
  • url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20171023&type=CRE title: Debate in Parliament
events/7
date
2017-10-24T00:00:00
type
Decision by Parliament, 1st reading
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-8-2017-0393_EN.html title: T8-0393/2017
summary
events/7
date
2017-10-24T00:00:00
type
Decision by Parliament, 1st reading/single reading
body
EP
docs
url: http://www.europarl.europa.eu/doceo/document/TA-8-2017-0393_EN.html title: T8-0393/2017
summary
procedure/Modified legal basis
Rules of Procedure EP 159
procedure/Other legal basis
Rules of Procedure EP 159
docs/4/body
EC
events/4/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2016-0359&language=EN
New
http://www.europarl.europa.eu/doceo/document/A-8-2016-0359_EN.html
events/7/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2017-0393
New
http://www.europarl.europa.eu/doceo/document/TA-8-2017-0393_EN.html
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: BONI Michał date: 2016-10-03T00:00:00 group: European People's Party (Christian Democrats) abbr: PPE
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
2016-10-03T00:00:00
rapporteur
name: BONI Michał group: European People's Party (Christian Democrats) abbr: PPE
committees/1
type
Committee Opinion
body
EP
associated
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
rapporteur
name: BUŞOI Cristian-Silviu date: 2016-10-10T00:00:00 group: European People's Party (Christian Democrats) abbr: PPE
committees/1
type
Committee Opinion
body
EP
associated
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
date
2016-10-10T00:00:00
rapporteur
name: BUŞOI Cristian-Silviu group: European People's Party (Christian Democrats) abbr: PPE
committees/1
type
Committee Opinion
body
EP
associated
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
date
2016-10-10T00:00:00
rapporteur
name: BUŞOI Cristian-Silviu group: European People's Party (Christian Democrats) abbr: PPE
committees/1
type
Committee Opinion
body
EP
associated
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
date
2016-10-10T00:00:00
rapporteur
name: BUŞOI Cristian-Silviu group: Group of European People's Party abbr: EPP
activities
  • date: 2016-08-29T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2016/0547/COM_COM(2016)0547_EN.pdf title: COM(2016)0547 type: Legislative proposal published celexid: CELEX:52016PC0547:EN body: EC commission: DG: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris type: Legislative proposal published
  • date: 2016-09-12T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: False committee: ENVI date: 2016-10-10T00:00:00 committee_full: Environment, Public Health and Food Safety rapporteur: group: EPP name: BUŞOI Cristian-Silviu body: EP responsible: True committee: LIBE date: 2016-10-03T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał
  • date: 2016-11-17T00:00:00 body: unknown type: Committee decision to open interinstitutional negotiations with report adopted in committee
  • date: 2016-11-17T00:00:00 body: EP type: Vote in committee, 1st reading/single reading committees: body: EP responsible: False committee: ENVI date: 2016-10-10T00:00:00 committee_full: Environment, Public Health and Food Safety rapporteur: group: EPP name: BUŞOI Cristian-Silviu body: EP responsible: True committee: LIBE date: 2016-10-03T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał
  • body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2016-0359&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0359/2016 type: Committee report tabled for plenary, 1st reading/single reading committees: body: EP responsible: False committee: ENVI date: 2016-10-10T00:00:00 committee_full: Environment, Public Health and Food Safety rapporteur: group: EPP name: BUŞOI Cristian-Silviu body: EP responsible: True committee: LIBE date: 2016-10-03T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał date: 2016-11-30T00:00:00
  • date: 2017-10-23T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20171023&type=CRE type: Debate in Parliament title: Debate in Parliament body: EP type: Debate in Parliament
  • date: 2017-10-24T00:00:00 docs: url: http://www.europarl.europa.eu/oeil/popups/sda.do?id=27940&l=en type: Results of vote in Parliament title: Results of vote in Parliament url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2017-0393 type: Decision by Parliament, 1st reading/single reading title: T8-0393/2017 body: EP type: Results of vote in Parliament
  • date: 2017-11-10T00:00:00 body: CSL type: Council Meeting council: Foreign Affairs meeting_id: 3573
  • date: 2017-11-10T00:00:00 body: EP/CSL type: Act adopted by Council after Parliament's 1st reading
  • date: 2017-11-15T00:00:00 body: CSL type: Final act signed
  • date: 2017-11-15T00:00:00 body: EP type: End of procedure in Parliament
  • date: 2017-11-21T00:00:00 type: Final act published in Official Journal docs: url: http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32017R2101 title: Regulation 2017/2101 url: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2017:305:TOC title: OJ L 305 21.11.2017, p. 0001
commission
  • body: EC dg: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
2016-10-03T00:00:00
rapporteur
name: BONI Michał group: European People's Party (Christian Democrats) abbr: PPE
committees/0
body
EP
responsible
False
committee
ENVI
date
2016-10-10T00:00:00
committee_full
Environment, Public Health and Food Safety
rapporteur
group: EPP name: BUŞOI Cristian-Silviu
committees/1
type
Committee Opinion
body
EP
associated
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
date
2016-10-10T00:00:00
rapporteur
name: BUŞOI Cristian-Silviu group: Group of European People's Party abbr: EPP
committees/1
body
EP
responsible
True
committee
LIBE
date
2016-10-03T00:00:00
committee_full
Civil Liberties, Justice and Home Affairs
rapporteur
group: EPP name: BONI Michał
council
  • body: CSL type: Council Meeting council: Foreign Affairs meeting_id: 3573 url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3573*&MEET_DATE=10/11/2017 date: 2017-11-10T00:00:00
docs
  • date: 2016-09-30T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE589.454 title: PE589.454 type: Committee draft report body: EP
  • date: 2016-10-28T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE593.828 title: PE593.828 type: Amendments tabled in committee body: EP
  • date: 2016-11-09T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE592.081&secondRef=02 title: PE592.081 committee: ENVI type: Committee opinion body: EP
  • date: 2017-11-15T00:00:00 docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=[%n4]%2F17&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC title: 00026/2017/LEX type: Draft final act body: CSL
  • date: 2017-12-06T00:00:00 docs: url: /oeil/spdoc.do?i=27940&j=0&l=en title: SP(2017)766 type: Commission response to text adopted in plenary
  • date: 2016-10-20T00:00:00 docs: url: http://www.connefof.europarl.europa.eu/connefof/app/exp/COM(2016)0547 title: COM(2016)0547 type: Contribution body: IT_SENATE
  • date: 2016-11-11T00:00:00 docs: url: http://www.connefof.europarl.europa.eu/connefof/app/exp/COM(2016)0547 title: COM(2016)0547 type: Contribution body: PT_PARLIAMENT
events
  • date: 2016-08-29T00:00:00 type: Legislative proposal published body: EC docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2016/0547/COM_COM(2016)0547_EN.pdf title: COM(2016)0547 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2016&nu_doc=0547 title: EUR-Lex summary: PURPOSE: to amend Regulation (EC) No 1920/2006 as regards information exchange, early warning system and risk assessment procedure on new psychoactive substances (NPS). PROPOSED ACT: Regulation of the European Parliament and of the Council. ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council. BACKGROUND: new psychoactive substances can pose serious cross border threats to health which makes necessary to enhance monitoring, early warning and combating of those threats. In 2015, 100 new substances were reported for the first time to the EU Early Warning System (EWS), bringing the total number of new substances monitored to more than 560 – with more than 380 (70%) of these detected in the last five years alone. On 17 September 2013, the Commission put forward a package of two legislative proposals on new psychoactive substances: (i) a proposal for a Regulation on new psychoactive substances and; (ii) a proposed Directive amending Council Framework Decision 2004/757/JHA laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking, as regards the definition of drug. Inter-institutional negotiations of this legislative package have been ongoing for more than two years . The European Parliament adopted its legislative resolutions on 17 April 2014. The Council did not adopt a general approach on the proposals; during the examination of the proposals Member States expressed doubts concerning the choice of Article 114 of the Treaty on the Functioning of the European Union (TFEU) as the legal basis for the proposed Regulation. In response to the agreement by COREPER on 6 April 2016 on a compromise approach proposed by the Netherlands Presidency of the Council to achieve the same objective of a swifter, more effective EU action on NPS, the Commission proposes targeted amendments of Regulation 1920/2006 integrating the draft provisions on early warning system and risk assessment procedure that were part of the 2013 Commission proposal for a Regulation on new psychoactive substances into the founding Regulation of the EMCDDA. The proposal reflects the priorities set out by the European Agenda on Security adopted on 28 April 2015. CONTENT: this proposal - based on Article 168(5) TFEU - seeks to amend Regulation (EC) No 1920/2006 in order to strengthen the EU early warning system and the risk assessment and streamline procedures to ensure more effective and fast action. In order to speed up the process, deadlines are substantially shortened compared to the current system based on Council Decision 2005/387/JHA. For the purpose of swift and effective collection of information on NPS, the EMCDDA should conclude working arrangements with Europol, the European Medicines Agency, the European Chemicals Agency and the European Food Safety Authority without undue delay following the publication of the Regulation in the Official Journal. This proposal also ensures a participation of EUROPOL in the early warning system and risk assessment procedure, in particular as input on the involvement of criminal groups in the manufacture and distribution of new psychoactive substances is concerned. According to Article 23 of Regulation 1920/2006 the Commission may propose, if appropriate, and in the light of developments in respect of regulatory agencies on the basis of the next evaluation of the Centre further amendments to the EMCDDA founding Regulation The following amendments to Regulation 1920/2006 seek to: clarify that tasks of the EMCDDA are information exchange and early warning on new psychoactive substances as well as risk assessment. The Centre also monitors all new psychoactive substances that have been reported by Member States; establish the respective roles of Member States, the EMCDDA and Europol in the process of exchange of information and early warning on new psychoactive substances; lay down the contents and the procedures for the drawing up and the transmission by the EMCDDA of an initial report on a new psychoactive substance. Europol, the European Medicines Agency, the European Chemicals Agency and the European Food Safety Authority are associated to the collection of information for an initial report; empower the Commission to request the EMCDDA to assess the risks of a new psychoactive substance on which an initial report has been drawn up. The proposal lays down the procedures for the risk assessment, which is to be conducted by the Scientific Committee of the EMCDDA, and for the drawing up and the transmission of a risk assessment report; detail circumstances in which no risk assessment is to be conducted on a new psychoactive substance. BUDGETARY IMPLICATIONS: the subsidy for the Centre forms already part of the Union's budget. However, for the Centre to adequately deal with the growing number of requests related to information exchange on new psychoactive substances as well as with the proposed streamlined procedures for the EU early warning system and risk assessment procedure, an amount of EUR 676 000 in total for the period 2017-2020 for the system development and an amount of EUR 100 000 per year to finance three additional contract agents will need to be added to the Centre's budget.
  • date: 2016-09-12T00:00:00 type: Committee referral announced in Parliament, 1st reading/single reading body: EP
  • date: 2016-11-17T00:00:00 type: Vote in committee, 1st reading/single reading body: EP
  • date: 2016-11-17T00:00:00 type: Committee decision to open interinstitutional negotiations with report adopted in committee body: EP
  • date: 2016-11-30T00:00:00 type: Committee report tabled for plenary, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2016-0359&language=EN title: A8-0359/2016 summary: The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Michal BONI (EPP, PL) on the proposal for a regulation of the European Parliament and of the Council amending Regulation (EC) No 1920/2006 as regards information exchange, early warning system and risk assessment procedure on new psychoactive substances. The committee recommended that Parliament’s position adopted in first reading following the ordinary legislative procedure should amend the Commission proposal as follows: Improve monitoring : bearing in mind the rapid growth of the market of those novel products, which continues to be challenging, the amended text stressed the need to enhance monitoring and early warning systems , to assess their health, safety and social risks in order to develop responses such as risk reduction measures in order to combat those threats. The Regulation should take into account the fact that vulnerable groups , and especially young people, are particularly exposed to the public health, safety and social risks arising from new psychoactive substances. Exchange of information, early warning system and risk assessment : Members proposed that provisions on new trends in the use of existing psychoactive substances should be maintained. Information provided to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and to Europol should also include distribution channels, trafficking and smuggling . The Centre, in cooperation with Europol, shall collect, analyse, assess, and communicate this information in a timely manner to Member States and to the Commission. The initial report on the new psychoactive substance should also give a first indication of safety risks . As one of the reasons of this report is to make the procedures limiting the dangerous new psychoactive substances shorter and more efficient, the information should be provided without undue delay to the Centre by the European Medicines Agency. Risk assessment report : this must contain: an analysis of the health risks associated with the new psychoactive substance, including contraindications for use with other substances, where available; an analysis of the social risks associated with the new psychoactive substance, in particular the involvement of criminal groups in the development, manufacture, distribution and distribution channels, trafficking and smuggling of the new psychoactive substance. The Scientific Committee assessing the risks posed by the new psychoactive substance may include a psychologist specialising in addiction. Exclusion from risk assessment : a substance not assumed dangerous on the international level could pose serious threats in the EU. Accordingly, if the data indicates this is needed, Members consider that it should be possible to conduct a risk assessment at Union level.
  • date: 2017-10-23T00:00:00 type: Debate in Parliament body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20171023&type=CRE title: Debate in Parliament
  • date: 2017-10-24T00:00:00 type: Results of vote in Parliament body: EP docs: url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=27940&l=en title: Results of vote in Parliament
  • date: 2017-10-24T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2017-0393 title: T8-0393/2017 summary: The European Parliament adopted by 609 votes to 19, with 29 abstentions, a resolution on the proposal for a regulation of the European Parliament and of the Council amending Regulation (EC) No 1920/2006 as regards information exchange, early warning system and risk assessment procedure on new psychoactive substances. The European Parliament’s position adopted at first reading under the ordinary legislative procedure amended the Commission proposal as follows: Improving monitoring : given the rapidly growing market for these new products, which remains challenging, the amended text stressed the need to enhance monitoring and early warning systems and to assess their health and social risks. Vulnerable groups , especially young people, are particularly exposed to the health and social risks associated with new psychoactive substances. Exchange of information, early warning system and risk assessment : the European Monitoring Center for Drugs and Drug Addiction (EMCDDA) in cooperation with Europol shall collect, collate, analyse and assess the information and communicate it in a timely manner to the national focal points and the Europol national units as well as to the Commission with a view to providing them with any information required for the purposes of early warning and for the purposes of allowing the Centre to draw up the initial report or the combined initial report. Initial report : an initial report shall be drawn up on a new psychoactive substance where information provided by the Member States on that new psychoactive substance gives rise to concerns that it might pose health or social risks at Union level. The initial report shall allow the Commission to make an informed decision regarding the launch of the risk assessment procedure. The risk assessment procedure at Union level should be undertaken rapidly. Where the a majority of the Member States considers that information shared on a new psychoactive substance gives rise to concerns that the new psychoactive substance may pose health or social risks at Union level, the Centre shall draw up an initial report on the new psychoactive substance. The amended text stated that the initial report shall contain a first indication of the nature, number and scale of incidents showing health and social problems in which the new psychoactive substance may potentially be involved, and the patterns of use of the new psychoactive substance. The initial report shall also contain information: on the human and veterinary medical use of the new psychoactive substance, including as an active substance in a medicinal product for human use or in a veterinary medicinal product; on the commercial and industrial use of the new psychoactive substance, the extent of such use, as well as its use for scientific research and development purposes. The Scientific Committee may be extended as deemed necessary by including experts representing the scientific fields relevant for ensuring a balanced assessment of the risks posed by the new psychoactive substance. Following the risk assessment procedure, the Commission shall determine whether the new psychoactive substance in question should be included in the definition of 'drug' in accordance with the procedure provided for in Council Framework Decision 2004/757/JHA. Exclusion from risk assessment : in principle, no risk assessment shall be carried out on a new psychoactive substance if it is subject to an assessment under international law , except where there are sufficient data and information available to suggest the need for a risk assessment report at Union level, the reasons for which shall be indicated in the initial report. In addition, no risk assessment shall be carried out on a new psychoactive substance if it is an active substance in a medicinal product for human use or in a veterinary medicinal product.
  • date: 2017-11-10T00:00:00 type: Act adopted by Council after Parliament's 1st reading body: EP/CSL
  • date: 2017-11-15T00:00:00 type: Final act signed body: CSL
  • date: 2017-11-15T00:00:00 type: End of procedure in Parliament body: EP
  • date: 2017-11-21T00:00:00 type: Final act published in Official Journal summary: PURPOSE: to strengthen the EU's early warning system and risk assessment procedure for new psychoactive substances (NPS). LEGISLATIVE ACT: Regulation (EU) 2017/2101 of the European Parliament and of the Council amending Regulation (EC) No 1920/2006 as regards information exchange on, and an early warning system and risk assessment procedure for, new psychoactive substances. CONTENT: this Regulation amends Regulation (EC) No 1920/2006 in order to strengthen surveillance and improve the early warning system and to assess the health and social risks associated with new psychoactive substances. The Regulation shall take into account that vulnerable groups , especially young people, are particularly exposed to the risks associated with these new substances. The main amendments adopted concern the following points: Exchange of information, early warning system and risk assessment : each Member State shall ensure that its national focal point and Europol national units provide the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the necessary information they have on the NSPs. The Centre, in cooperation with Europol, shall collect, collate, analyse and assess the information and communicate it in a timely manner to the national focal points and the Europol national units as well as to the Commission with a view to providing them with any information required for the purposes of early warning and for the purposes of allowing the Centre to draw up the initial report. Initial report : where the Centre, the Commission or a majority of the Member States considers that information shared on a new psychoactive substance collected in one or more Member States gives rise to concerns that the new psychoactive substance may pose health or social risks at Union level, the Centre shall draw up an initial report on the new psychoactive substance. The initial report shall allow the Commission to make an informed decision regarding the launch of the risk assessment procedure. Europol, the European Medicines Agency, the European Centre for Disease Prevention and Control, the European Chemicals Agency and the European Food Safety Authority shall be involved in collecting information for the preparation of the initial reports. Risk assessment procedure and report : within two weeks of receipt of an initial report, the Commission may request the Centre to assess the potential risks posed by the new psychoactive substance and to draw up a risk assessment report. The Centre shall submit the risk assessment report or the combined risk assessment report to the Commission and the Member States within six weeks of receipt of the request from the Commission to draw up a risk assessment report. Following the risk assessment procedure, the Commission shall determine whether the new psychoactive substance in question should be included in the definition of ‘drug’ in accordance with the procedure provided for in Council Framework Decision 2004/757/JHA . Exclusion from risk assessment : no risk assessment shall be carried out where the new psychoactive substance is at an advanced stage of assessment within the United Nations system. No risk assessment shall be carried out where the new psychoactive substance is an active substance in a medicinal product for human use or in a veterinary medicinal product that has obtained a marketing authorisation. ENTRY INTO FORCE: 22.11.2017. APPLICATION: from 23.11.2018. docs: title: Regulation 2017/2101 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32017R2101 title: OJ L 305 21.11.2017, p. 0001 url: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2017:305:TOC
links
other
  • body: EC dg: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
otherinst
  • name: European Economic and Social Committee
  • name: European Committee of the Regions
procedure/Mandatory consultation of other institutions
European Economic and Social Committee European Committee of the Regions
procedure/Modified legal basis
Old
Rules of Procedure EP 150
New
Rules of Procedure EP 159
procedure/dossier_of_the_committee
Old
LIBE/8/07650
New
  • LIBE/8/07650
procedure/final/url
Old
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32017R2101
New
https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32017R2101
procedure/instrument
Old
Regulation
New
  • Regulation
  • Amending Regulation (EC) No 1920/2006 2005/0166(COD)
procedure/other_consulted_institutions
European Economic and Social Committee European Committee of the Regions
procedure/subject
Old
  • 7.30.30.04 Action to combat drugs and drug-trafficking
  • 8.40.08 Agencies and bodies of the EU
New
7.30.30.04
Action to combat drugs and drug-trafficking
8.40.08
Agencies and bodies of the EU
procedure/summary
  • Amending Regulation (EC) No 1920/2006
activities/6/docs/0
url
http://www.europarl.europa.eu/oeil/popups/sda.do?id=27940&l=en
type
Results of vote in Parliament
title
Results of vote in Parliament
activities/6/type
Old
Decision by Parliament, 1st reading/single reading
New
Results of vote in Parliament
activities/11
date
2017-11-21T00:00:00
text

PURPOSE: to strengthen the EU's early warning system and risk assessment procedure for new psychoactive substances (NPS).

LEGISLATIVE ACT: Regulation (EU) 2017/2101 of the European Parliament and of the Council amending Regulation (EC) No 1920/2006 as regards information exchange on, and an early warning system and risk assessment procedure for, new psychoactive substances.

CONTENT: this Regulation amends Regulation (EC) No 1920/2006 in order to strengthen surveillance and improve the early warning system and to assess the health and social risks associated with new psychoactive substances. The Regulation shall take into account that vulnerable groups, especially young people, are particularly exposed to the risks associated with these new substances.

The main amendments adopted concern the following points:

Exchange of information, early warning system and risk assessment: each Member State shall ensure that its national focal point and Europol national units provide the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the necessary information they have on the NSPs.

The Centre, in cooperation with Europol, shall collect, collate, analyse and assess the information and communicate it in a timely manner to the national focal points and the Europol national units as well as to the Commission with a view to providing them with any information required for the purposes of early warning and for the purposes of allowing the Centre to draw up the initial report.

Initial report: where the Centre, the Commission or a majority of the Member States considers that information shared on a new psychoactive substance collected in one or more Member States gives rise to concerns that the new psychoactive substance may pose health or social risks at Union level, the Centre shall draw up an initial report on the new psychoactive substance.

The initial report shall allow the Commission to make an informed decision regarding the launch of the risk assessment procedure. Europol, the European Medicines Agency, the European Centre for Disease Prevention and Control, the European Chemicals Agency and the European Food Safety Authority shall be involved in collecting information for the preparation of the initial reports.

Risk assessment procedure and report: within two weeks of receipt of an initial report, the Commission may request the Centre to assess the potential risks posed by the new psychoactive substance and to draw up a risk assessment report. The Centre shall submit the risk assessment report or the combined risk assessment report to the Commission and the Member States within six weeks of receipt of the request from the Commission to draw up a risk assessment report. Following the risk assessment procedure, the Commission shall determine whether the new psychoactive substance in question should be included in the definition of ‘drug’ in accordance with the procedure provided for in Council Framework Decision 2004/757/JHA.

Exclusion from risk assessment: no risk assessment shall be carried out where the new psychoactive substance is at an advanced stage of assessment within the United Nations system.

No risk assessment shall be carried out where the new psychoactive substance is an active substance in a medicinal product for human use or in a veterinary medicinal product that has obtained a marketing authorisation.

ENTRY INTO FORCE: 22.11.2017.

APPLICATION: from 23.11.2018.

type
Final act published in Official Journal
docs
procedure/Modified legal basis
Old
Rules of Procedure of the European Parliament EP 150
New
Rules of Procedure EP 150
procedure/final
url
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32017R2101
title
Regulation 2017/2101
procedure/stage_reached
Old
Procedure completed, awaiting publication in Official Journal
New
Procedure completed
activities/10
date
2017-11-15T00:00:00
body
EP
type
End of procedure in Parliament
activities/7
date
2017-11-10T00:00:00
body
CSL
type
Council Meeting
council
Foreign Affairs
meeting_id
3573
activities/8
date
2017-11-10T00:00:00
body
EP/CSL
type
Act adopted by Council after Parliament's 1st reading
activities/9
date
2017-11-15T00:00:00
body
CSL
type
Final act signed
procedure/stage_reached
Old
Provisional agreement between Parliament and Council on final act
New
Procedure completed, awaiting publication in Official Journal
activities/6/docs/0/text
  • The European Parliament adopted by 609 votes to 19, with 29 abstentions, a resolution on the proposal for a regulation of the European Parliament and of the Council amending Regulation (EC) No 1920/2006 as regards information exchange, early warning system and risk assessment procedure on new psychoactive substances.

    The European Parliament’s position adopted at first reading under the ordinary legislative procedure amended the Commission proposal as follows:

    Improving monitoring: given the rapidly growing market for these new products, which remains challenging, the amended text stressed the need to enhance monitoring and early warning systems and to assess their health and social risks.

    Vulnerable groups, especially young people, are particularly exposed to the health and social risks associated with new psychoactive substances.

    Exchange of information, early warning system and risk assessment: the European Monitoring Center for Drugs and Drug Addiction (EMCDDA) in cooperation with Europol shall collect, collate, analyse and assess the information and communicate it in a timely manner to the national focal points and the Europol national units as well as to the Commission with a view to providing them with any information required for the purposes of early warning and for the purposes of allowing the Centre to draw up the initial report or the combined initial report.

    Initial report: an initial report shall be drawn up on a new psychoactive substance where information provided by the Member States on that new psychoactive substance gives rise to concerns that it might pose health or social risks at Union level. The initial report shall allow the Commission to make an informed decision regarding the launch of the risk assessment procedure. The risk assessment procedure at Union level should be undertaken rapidly.

    Where the a majority of the Member States considers that information shared on a new psychoactive substance gives rise to concerns that the new psychoactive substance may pose health or social risks at Union level, the Centre shall draw up an initial report on the new psychoactive substance.

    The amended text stated that the initial report shall contain a first indication of the nature, number and scale of incidents showing health and social problems in which the new psychoactive substance may potentially be involved, and the patterns of use of the new psychoactive substance.

    The initial report shall also contain information:

    • on the human and veterinary medical use of the new psychoactive substance, including as an active substance in a medicinal product for human use or in a veterinary medicinal product;
    • on the commercial and industrial use of the new psychoactive substance, the extent of such use, as well as its use for scientific research and development purposes.

    The Scientific Committee may be extended as deemed necessary by including experts representing the scientific fields relevant for ensuring a balanced assessment of the risks posed by the new psychoactive substance.

    Following the risk assessment procedure, the Commission shall determine whether the new psychoactive substance in question should be included in the definition of 'drug' in accordance with the procedure provided for in Council Framework Decision 2004/757/JHA.

    Exclusion from risk assessment: in principle, no risk assessment shall be carried out on a new psychoactive substance if it is subject to an assessment under international law, except where there are sufficient data and information available to suggest the need for a risk assessment report at Union level, the reasons for which shall be indicated in the initial report. In addition, no risk assessment shall be carried out on a new psychoactive substance if it is an active substance in a medicinal product for human use or in a veterinary medicinal product.

activities/6/docs/0/url
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2017-0393
procedure/stage_reached
Old
Awaiting Council 1st reading position / budgetary conciliation convocation
New
Provisional agreement between Parliament and Council on final act
activities/5/docs
  • url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20171023&type=CRE type: Debate in Parliament title: Debate in Parliament
activities/5/type
Old
Debate in plenary scheduled
New
Debate in Parliament
activities/6/docs
  • type: Decision by Parliament, 1st reading/single reading title: T8-0393/2017
activities/6/type
Old
Vote in plenary scheduled
New
Decision by Parliament, 1st reading/single reading
procedure/stage_reached
Old
Awaiting Parliament 1st reading / single reading / budget 1st stage
New
Awaiting Council 1st reading position / budgetary conciliation convocation
activities/5
date
2017-10-23T00:00:00
body
EP
type
Debate in plenary scheduled
activities/6/type
Old
Indicative plenary sitting date, 1st reading/single reading
New
Vote in plenary scheduled
activities/0
date
2016-08-29T00:00:00
docs
url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2016/0547/COM_COM(2016)0547_EN.pdf celexid: CELEX:52016PC0547:EN type: Legislative proposal published title: COM(2016)0547
body
EC
type
Legislative proposal published
commission
DG: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris
activities/4
body
EP
docs
url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2016-0359&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0359/2016
type
Committee report tabled for plenary, 1st reading/single reading
committees
date
2016-11-30T00:00:00
procedure/Mandatory consultation of other institutions
European Economic and Social Committee European Committee of the Regions
activities/0
date
2016-08-29T00:00:00
docs
url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2016/0547/COM_COM(2016)0547_EN.pdf celexid: CELEX:52016PC0547:EN type: Legislative proposal published title: COM(2016)0547
type
Legislative proposal published
body
EC
commission
DG: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris
activities/4
body
EP
docs
url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2016-0359&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0359/2016
type
Committee report tabled for plenary, 1st reading/single reading
committees
date
2016-11-30T00:00:00
procedure/Mandatory consultation of other institutions
European Economic and Social Committee European Committee of the Regions
activities/5/date
Old
2017-11-14T00:00:00
New
2017-10-24T00:00:00
activities/5/date
Old
2017-09-12T00:00:00
New
2017-11-14T00:00:00
activities/5
date
2017-09-12T00:00:00
body
EP
type
Indicative plenary sitting date, 1st reading/single reading
activities/0
date
2016-08-29T00:00:00
docs
url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2016/0547/COM_COM(2016)0547_EN.pdf celexid: CELEX:52016PC0547:EN type: Legislative proposal published title: COM(2016)0547
body
EC
type
Legislative proposal published
commission
DG: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris
activities/0/body
Old
EP
New
EC
activities/0/commission
  • DG: url: http://ec.europa.eu/info/departments/migration-and-home-affairs_en title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris
activities/0/date
Old
2017-06-13T00:00:00
New
2016-08-29T00:00:00
activities/0/docs
  • url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2016/0547/COM_COM(2016)0547_EN.pdf title: COM(2016)0547 type: Legislative proposal published celexid: CELEX:52016PC0547:EN
activities/0/type
Old
Indicative plenary sitting date, 1st reading/single reading
New
Legislative proposal published
activities/5
date
2017-06-13T00:00:00
body
EP
type
Indicative plenary sitting date, 1st reading/single reading
activities/0/commission/0/DG/url
Old
http://ec.europa.eu/dgs/home-affairs/
New
http://ec.europa.eu/info/departments/migration-and-home-affairs_en
other/0/dg/url
Old
http://ec.europa.eu/dgs/home-affairs/
New
http://ec.europa.eu/info/departments/migration-and-home-affairs_en
procedure/Mandatory consultation of other institutions
Old
Economic and Social Committee Committee of the Regions
New
European Economic and Social Committee European Committee of the Regions
activities/0/docs/0/celexid
CELEX:52016PC0547:EN
activities/0/docs/0/celexid
CELEX:52016PC0547:EN
activities/4/docs/0/text
  • The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Michal BONI (EPP, PL) on the proposal for a regulation of the European Parliament and of the Council amending Regulation (EC) No 1920/2006 as regards information exchange, early warning system and risk assessment procedure on new psychoactive substances.

    The committee recommended that Parliament’s position adopted in first reading following the ordinary legislative procedure should amend the Commission proposal as follows:

    Improve monitoring: bearing in mind the rapid growth of the market of those novel products, which continues to be challenging, the amended text stressed the need to enhance monitoring and early warning systems, to assess their health, safety and social risks in order to develop responses such as risk reduction measures in order to combat those threats.

    The Regulation should take into account the fact that vulnerable groups, and especially young people, are particularly exposed to the public health, safety and social risks arising from new psychoactive substances.

    Exchange of information, early warning system and risk assessment: Members proposed that provisions on new trends in the use of existing psychoactive substances should be maintained. Information provided to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and to Europol should also include distribution channels, trafficking and smuggling. The Centre, in cooperation with Europol, shall collect, analyse, assess, and communicate this information in a timely manner to Member States and to the Commission.

    The initial report on the new psychoactive substance should also give a first indication of safety risks. As one of the reasons of this report is to make the procedures limiting the dangerous new psychoactive substances shorter and more efficient, the information should be provided without undue delay to the Centre by the European Medicines Agency.

    Risk assessment report: this must contain:

    • an analysis of the health risks associated with the new psychoactive substance, including contraindications for use with other substances, where available;
    • an analysis of the social risks associated with the new psychoactive substance, in particular the involvement of criminal groups in the development, manufacture, distribution and distribution channels, trafficking and smuggling of the new psychoactive substance.

    The Scientific Committee assessing the risks posed by the new psychoactive substance may include a psychologist specialising in addiction. 

    Exclusion from risk assessment: a substance not assumed dangerous on the international level could pose serious threats in the EU. Accordingly, if the data indicates this is needed, Members consider that it should be possible to conduct a risk assessment at Union level.

activities/4/docs
  • url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2016-0359&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0359/2016
activities/4
date
2016-11-30T00:00:00
body
EP
type
Committee report tabled for plenary, 1st reading/single reading
committees
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament 1st reading / single reading / budget 1st stage
activities/1/committees/0/date
2016-10-10T00:00:00
activities/1/committees/0/rapporteur
  • group: EPP name: BUŞOI Cristian-Silviu
activities/2
date
2016-11-17T00:00:00
body
unknown
type
Committee decision to open interinstitutional negotiations with report adopted in committee
activities/3
date
2016-11-17T00:00:00
body
EP
type
Vote in committee, 1st reading/single reading
committees
committees/0/date
2016-10-10T00:00:00
committees/0/rapporteur
  • group: EPP name: BUŞOI Cristian-Silviu
procedure/Modified legal basis
Rules of Procedure of the European Parliament EP 150
activities/1/committees/1/date
2016-10-03T00:00:00
activities/1/committees/1/rapporteur
  • group: EPP name: BONI Michał
committees/1/date
2016-10-03T00:00:00
committees/1/rapporteur
  • group: EPP name: BONI Michał
activities/0/docs/0/text
  • PURPOSE: to amend Regulation (EC) No 1920/2006 as regards information exchange, early warning system and risk assessment procedure on new psychoactive substances (NPS).

    PROPOSED ACT: Regulation of the European Parliament and of the Council.

    ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council.

    BACKGROUND: new psychoactive substances can pose serious cross border threats to health which makes necessary to enhance monitoring, early warning and combating of those threats.

    In 2015, 100 new substances were reported for the first time to the EU Early Warning System (EWS), bringing the total number of new substances monitored to more than 560 – with more than 380 (70%) of these detected in the last five years alone.

    On 17 September 2013, the Commission put forward a package of two legislative proposals on new psychoactive substances: (i) a proposal for a Regulation on new psychoactive substances and; (ii) a proposed Directive amending Council Framework Decision 2004/757/JHA laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking, as regards the definition of drug.

    Inter-institutional negotiations of this legislative package have been ongoing for more than two years. The European Parliament adopted its legislative resolutions on 17 April 2014. The Council did not adopt a general approach on the proposals; during the examination of the proposals Member States expressed doubts concerning the choice of Article 114 of the Treaty on the Functioning of the European Union (TFEU) as the legal basis for the proposed Regulation.

    In response to the agreement by COREPER on 6 April 2016 on a compromise approach proposed by the Netherlands Presidency of the Council to achieve the same objective of a swifter, more effective EU action on NPS, the Commission proposes targeted amendments of Regulation 1920/2006 integrating the draft provisions on early warning system and risk assessment procedure that were part of the 2013 Commission proposal for a Regulation on new psychoactive substances into the founding Regulation of the EMCDDA.

    The proposal reflects the priorities set out by the European Agenda on Security adopted on 28 April 2015.

    CONTENT: this proposal - based on Article 168(5) TFEU - seeks to amend Regulation (EC) No 1920/2006 in order to strengthen the EU early warning system and the risk assessment and streamline procedures to ensure more effective and fast action.

    In order to speed up the process, deadlines are substantially shortened compared to the current system based on Council Decision 2005/387/JHA.

    For the purpose of swift and effective collection of information on NPS, the EMCDDA should conclude working arrangements with Europol, the European Medicines Agency, the European Chemicals Agency and the European Food Safety Authority without undue delay following the publication of the Regulation in the Official Journal.

    This proposal also ensures a participation of EUROPOL in the early warning system and risk assessment procedure, in particular as input on the involvement of criminal groups in the manufacture and distribution of new psychoactive substances is concerned. 

    According to Article 23 of Regulation 1920/2006 the Commission may propose, if appropriate, and in the light of developments in respect of regulatory agencies on the basis of the next evaluation of the Centre further amendments to the EMCDDA founding Regulation

    The following amendments to Regulation 1920/2006 seek to:

    • clarify that tasks of the EMCDDA are information exchange and early warning on new psychoactive substances as well as risk assessment. The Centre also monitors all new psychoactive substances that have been reported by Member States;
    • establish the respective roles of Member States, the EMCDDA and Europol in the process of exchange of information and early warning on new psychoactive substances;
    • lay down the contents and the procedures for the drawing up and the transmission by the EMCDDA of an initial report on a new psychoactive substance. Europol, the European Medicines Agency, the European Chemicals Agency and the European Food Safety Authority are associated to the collection of information for an initial report;
    • empower the Commission to request the EMCDDA to assess the risks of a new psychoactive substance on which an initial report has been drawn up. The proposal lays down the procedures for the risk assessment, which is to be conducted by the Scientific Committee of the EMCDDA, and for the drawing up and the transmission of a risk assessment report;
    • detail circumstances in which no risk assessment is to be conducted on a new psychoactive substance.

    BUDGETARY IMPLICATIONS: the subsidy for the Centre forms already part of the Union's budget. However, for the Centre to adequately deal with the growing number of requests related to information exchange on new psychoactive substances as well as with the proposed streamlined procedures for the EU early warning system and risk assessment procedure, an amount of EUR 676 000 in total for the period 2017-2020 for the system development and an amount of EUR 100 000 per year to finance three additional contract agents will need to be added to the Centre's budget.

activities
  • date: 2016-08-29T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2016/0547/COM_COM(2016)0547_EN.pdf celexid: CELEX:52016PC0547:EN type: Legislative proposal published title: COM(2016)0547 body: EC type: Legislative proposal published commission: DG: url: http://ec.europa.eu/dgs/home-affairs/ title: Migration and Home Affairs Commissioner: AVRAMOPOULOS Dimitris
  • date: 2016-09-12T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP responsible: True committee_full: Civil Liberties, Justice and Home Affairs committee: LIBE
committees
  • body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI
  • body: EP responsible: True committee_full: Civil Liberties, Justice and Home Affairs committee: LIBE
links
other
  • body: EC dg: url: http://ec.europa.eu/dgs/home-affairs/ title: Migration and Home Affairs commissioner: AVRAMOPOULOS Dimitris
procedure
dossier_of_the_committee
LIBE/8/07650
Mandatory consultation of other institutions
Economic and Social Committee Committee of the Regions
reference
2016/0261(COD)
instrument
Regulation
legal_basis
Treaty on the Functioning of the EU TFEU 168-p5
stage_reached
Awaiting committee decision
summary
Amending Regulation (EC) No 1920/2006
subtype
Legislation
title
New psychoactive substances: information exchange, early warning system and risk assessment procedure
type
COD - Ordinary legislative procedure (ex-codecision procedure)
subject